1. Home
  2. Diagnoses & Conditions
  3. Diagnosis Prevalence List

Diagnosis Prevalence List

Though these numbers are based on studies that vary in design and populations and may involve assumptions about patient age distributions, they should reasonably reflect relative prevalences among children in primary care practices. Some listed conditions may not be considered medical diagnoses. Click Feedback for questions or to suggest better prevalence studies.

Practice Size:
Sort by Diagnosis Sort by Prevalence Patients in your practice Citation
Childhood Obesity 1/5 500 [Robert: 2018]
≥1 Mental, Emotional, Behavioral Disorder 1/6 417 [O'Connell: 2009]
Constipation 1/8 312 [Mugie: 2011]
Asthma (Pediatric) 1/12 208 [National: 2016]
Attention Deficit Hyperactivity Disorder (9.4% of 2-17 year olds) 1/12 208 [Division: 2018]
Substance Use Disorders 1/13 192 [Han: 2015]
Headache, Migraine 1/13 192 [Lewis,: 2002]
Depression 1/20 125 [Birmaher: 2007]
Hypertension 1/22 114 [Sorof: 2004]
LGBT (adults, US) 1/24 104 [Gates: 2017]
Food Allergy 1/27 93 [Branum: 2009]
Anxiety Disorder (cumulative by age 16; adj.) 1/30 83 [Costello: 2003]
Speech Defects 1/38 66 [Newacheck: 1992]
Autism Spectrum Disorder 1/60 42 [Baio: 2018]
Premature Infant (<27 weeks) 1/100 25 [McCormick: 2011]
Intellectual Disability 1/100 25 [American: 2013]
Tourette Syndrome 1/100 25 [Khalifa: 2005]
Headache, Chronic Daily 1/100 25 [Lipton: 2011]
Congenital Heart Defects, all 1/110 23 [Hugh: 2016]
Celiac Disease (all ages) 1/133 19 [Fasano: 2003]
Transgender (prevalence in US adults) 1/167 15 [Flores: 2016]
In Foster Care (national estimate) 1/185 14 [Administration: 2011]
Fetal Alcohol Spectrum Disorders 1/200 12 [National: 2017]
Seizure Disorder 1/256 10 [Hirtz: 2007]
Hearing Loss 1/333 8 [Finitzo: 1998]
Cerebral Palsy 1/474 5 [Oskoui: 2013]
Familial Hypercholesterolemia (heterozygote) 1/500 5 [Jorde: 2010]
Diabetes Mellitus, Type I, in children 1/588 4 [Diabetes: 2005]
Ventricular Septal Defect 1/593 4 [Bernstein: 2004]
Cancer (all types, includes survivors) 1/725 3 [Hewitt: 2003]
Neural Tube Defects 1/760 3 [Utah: 2000]
Eosinophilic Esophagitis 1/847 3 [Robson: 2019]
Down Syndrome 1/884 3 [de: 2017]
Hearing Loss or Deafness, Congenital 1/909 3 [Mehra: 2009]
Visual Impairment (worse than 20/70) 1/935 3 [Mervis: 2002]
Hearing Loss, Serious (>40 db, bilat.) 1/935 3 [Mervis: 2002]
Cleft Lip, with or without cleft palate 1/940 3 [Parker: 2010]
Transgender adolescents (0.73% of 13-17 year olds) 1/978 3 [Herman: 2017]
Juvenile Arthritis 1/1,000 2 [von: 2001]
XXY (Klinefelter) Syndrome 1/1,000 2 [Morris: 2008]
Club Foot 1/1,000 2 [Jorde: 2010]
Stroke (>6/100,000/yr. x 16 yr.) 1/1,042 2 [Roach: 2000]
Idiopathic Thrombocytopenic Purpura (cum. incidence) 1/1,070 2 [Chu: 2000]
Hydrocephalus 1/1,220 2 [Persson: 2005]
Inflammatory Bowel Disease 1/1,408 2 [Kappelman: 2007]
Cleft palate, without cleft lip 1/1,574 2 [Parker: 2010]
Tetralogy of Fallot 1/1,657 2 [Parker: 2010]
Rheumatic Heart Disease 1/2,000 1 [Chin: 2006]
Rectal & Large Intestinal Atresia/Stenosis 1/2,138 1 [Parker: 2010]
Congenital Hypothyroidism 1/2,174 1 [Maniatis: 2006]
Crohn's Disease 1/2,193 1 [Kugathasan: 2003]
Gastroschisis 1/2,229 1 [Parker: 2010]
Patent Ductus Arteriosus 1/2,329 1 [Bernstein: 2004]
Atrial Septal Defect 1/2,329 1 [Bernstein: 2004]
All Tandem Mass-Screened Conditions 1/2,400 1 [Schulze: 2003]
Sickle Cell Disease (national estimate) 1/2,699 0.9 [Hassell: 2010]
Pulmonary Valve Stenosis 1/2,717 0.9 [Bernstein: 2004]
Coarctation of the Aorta 1/2,717 0.9 [Bernstein: 2004]
Spinal Cord Injury 1/2,861 0.9 [National: 2005]
Reduction Defects, upper limbs 1/2,869 0.9 [Parker: 2010]
Traumatic Brain Injury w/ persistent disability 1/3,190 0.8 [Zaloshnja: 2008]
d-Transposition of the Great Arteries 1/3,333 0.8 [Parker: 2010]
Growth Hormone Deficiency 1/3,480 0.7 [Lindsay: 1994]
Cystic Fibrosis 1/3,500 0.7 [Comeau: 2004]
Childhood Absence Epilepsy 1/3,571 0.7 [Posner: 2008]
Aortic Valve Stenosis 1/3,622 0.7 [Bernstein: 2004]
Trisomy 18 1/3,762 0.7 [Parker: 2010]
Amino Acid Disorders - total 1/3,800 0.7 [Schulze: 2003]
Diaphragmatic Hernia 1/3,836 0.7 [Parker: 2010]
Lennox-Gastaut syndrome 1/3,850 0.6 [Trevathan: 1997]
Neurofibromatosis, Type I 1/4,000 0.6 [Jorde: 2010]
Turner Syndrome (1/2000 females) 1/4,000 0.6 [Stochholm: 2006]
22q11.2 deletion syndrome 1/4,000 0.6 [McDonald-McGinn: 2011]
Hypoplastic Left Heart Syndrome 1/4,344 0.6 [Parker: 2010]
Esophageal/Tracheoesophageal Atresia 1/4,608 0.5 [Parker: 2010]
Infantile Spasms 1/5,000 0.5 [Mackay: 2004]
Hirschsprung Disease 1/5,100 0.5 [Passarge: 2002]
Fragile X Syndrome 1/5,161 0.5 [Coffee: 2009]
Anophthalmia/Microphthalmia 1/5,349 0.5 [Parker: 2010]
Omphalocele 1/5,386 0.5 [Parker: 2010]
Charcot-Marie-Tooth Disease 1/5,714 0.4 [Morocutti: 2002]
Reduction defects, lower limbs 1/5,949 0.4 [Parker: 2010]
Duchenne Muscular Dystrophy 1/7,000 0.4 [Jorde: 2010]
Osteogenesis Imperfecta 1/7,500 0.3 [Jorde: 2010]
Leukodystrophies 1/7,663 0.3 [Bonkowsky: 2010]
Trisomy 13 1/7,906 0.3 [Parker: 2010]
Hypoplastic Right Ventricle 1/8,150 0.3 [Bernstein: 2004]
Deafness 1/10,000 0.3 [Marazita: 1993]
Romano-Ward Syndrome 1/10,000 0.3 [Ackerman: 1998]
Fatty Acid Oxidation Disorders - total 1/10,400 0.2 [Schulze: 2003]
Total Anomalous Pulmonary Venous Return 1/10,867 0.2 [Bernstein: 2004]
Single Ventricle 1/10,867 0.2 [Bernstein: 2004]
Rett Syndrome 1/11,364 0.2 [Laurvick: 2006]
Chronic Renal Failure 1/13,387 0.2 [Ardissino: 2003]
Truncus Arteriosus 1/13,876 0.2 [Parker: 2010]
Hemophilia (A & B) 1/14,588 0.2 [Soucie: 1998]
Organic Acidurias - total 1/14,700 0.2 [Schulze: 2003]
Congenital Adrenal Hyperplasia 1/15,000 0.2 [Pang: 1997]
Primary Ciliary Dyskinesia (immotile cilia) 1/15,000 0.2 [Knowles: 2013]
Marfan Syndrome 1/15,000 0.2 [Jorde: 2010]
Angelman Syndrome 1/16,000 0.2 [Kyllerman: 2013]
Phenylketonuria (PKU) 1/16,500 0.2 [Therrell: 2014]
Retinoblastoma 1/16,667 0.1 [Seregard: 2004]
Dilated Cardiomyopathy (0.57/100,000/yr.) 1/17,268 0.1 [Towbin: 2006]
MCADD 1/17,759 0.1 [Therrell: 2014]
Hemophilia A 1/18,619 0.1 [Soucie: 1998]
Tuberous Sclerosis 1/20,000 0.1 [Northrup: 2013]
Glycogen Metabolism/Storage Diseases 1/20,000 0.1
Huntington Disease 1/20,000 0.1 [Jorde: 2010]
Polycystic Kidney Disease, autsomal recessive 1/20,000 0.1 [Zerres: 1998]
Ataxia-Telangiectasia 1/20,000 0.1 [Rothblum-Oviatt: 2016]
Biotinidase deficiency, partial 1/24,957 0.1 [Therrell: 2014]
Prader-Willi Syndrome 1/25,000 0.1 [Butler: 1990]
Multiple Sclerosis 1/25,000 0.1 [Marrie: 2018]
Acute Lymphoblastic Leukemia (ALL) 1/33,333 0.08 [U.S.: 2005]
Cancer, brain & CNS 1/34,483 0.07 [U.S.: 2005]
Spinal Muscular Atrophy (SMA) 1/50,000 0.05 [Verhaart: 2017]
Myotonic Muscular Dystrophy 1/50,000 0.05 [Theadom: 2014]
Fabry Disease 1/50,000 0.05 [National: 2012]
Cornelia de Lange Syndrome 1/50,000 0.05 [Barisic: 2008]
Friedreich's Ataxia 1/50,000 0.05 [Durr: 1996]
VLCADD 1/63,000 0.04 [Therrell: 2014]
Hemophilia B 1/67,413 0.04 [Soucie: 1998]
Biotinidase deficiency, profound 1/67,766 0.04 [Therrell: 2014]
Methylmalonic Acidemia 1/75,000 0.03 [Chace: 2001]
Short-Chain Acyl-CoA Dehydrogenase Deficiency (SCADD) 1/83,300 0.03 [Schulze: 2003]
Hodgkin Lymphoma 1/83,333 0.03 [U.S.: 2005]
Non-Hodgkin Lymphoma 1/90,909 0.03 [U.S.: 2005]
Mucopolysaccharidosis Type I 1/100,000 0.03 [Moore: 2008]
Hurler Syndrome (Mucopolysaccharidosis type I) 1/100,000 0.03 [NINDS: 2006]
Cancer, bone & joint 1/111,111 0.02 [U.S.: 2005]
Guanidinoacetate Methyltransferase (GAMT) 1/114,000 0.02 [Mercimek-Mahmutoglu: 2015]
Tyrosinemia Type 1 1/120,000 0.02 [Scriver: 2001]
Neuroblastoma 1/131,579 0.02 [U.S.: 2005]
Acute Myeloid Leukemia (AML) 1/142,857 0.02 [U.S.: 2005]
Cancer, kidney & renal pelvis 1/166,667 0.01 [U.S.: 2005]
Wilms Tumor 1/172,414 0.01 [U.S.: 2005]
Maple Syrup Urine Disease 1/197,714 0.01 [Therrell: 2014]
Propionic Acidemia 1/238,346 0.01 [Therrell: 2014]
Isovaleric Acidemia 1/250,000 0.01 [Ensenauer: 2004]
Behçet's Disease 1/263,158 0.009 [Sakane: 1999]
Homocystinuria 1/300,000 0.008 [Shinawi: 2007]
LCHAD Deficiency 1/363,738 0.007 [Therrell: 2014]
Chronic Granulomatous Disease 1/500,000 0.005
Myasthenia Gravis 1/500,000 0.005
Familial Hypercholesterolemia (homozygote) 1/1,000,000 0.003
TFP Deficiency 1/1,822,568 0.001 [Therrell: 2014]
Arginase deficiency 1/2,000,000 0.001 [Nagata: 1991]